linagliptin
ItalyDrugs containing this active substance
-
It is used for the treatment of type 2 diabetes in adults aged 18 years and older, when the disease cannot be controlled with metformin and/or sulfonylurea alone.
Form: tablets, film-coated
Active substance Dosage empagliflozin - linagliptin - ATC: A10BD19
Manufacturer: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
-
This medicine is used to control blood sugar levels in adults with type 2 diabetes mellitus. It works by improving insulin production and effect after meals and by reducing the production of sugar by the body.
Form: tablets, film-coated
Active substance Dosage linagliptin - metformin hydrochloride - ATC: A10BD11
Manufacturer: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
-
It is used for the treatment of type 2 diabetes in adults, when the disease cannot be adequately controlled by diet, exercise, or other antidiabetic drugs such as metformin or sulfonylureas alone.
Form: tablets, film-coated
Active substance Dosage linagliptin - ATC: A10BH05
Manufacturer: Abdi Farma GmbH
-
It is used for the treatment of type 2 diabetes in adults, when the disease cannot be adequately controlled by diet, exercise, or other antidiabetic drugs such as metformin or sulfonylureas alone.
Form: tablets, film-coated
Active substance Dosage linagliptin - ATC: A10BH05
Manufacturer: AUROBINDO PHARMA (ITALIA) S.R.L.
-
It is used for the treatment of type 2 diabetes in adults when the disease cannot be adequately controlled by diet, exercise, or other antidiabetic drugs (such as metformin or sulfonylureas) alone.
Form: tablets, film-coated
Active substance Dosage linagliptin - ATC: A10BH05
Manufacturer: EG S.P.A.
-
It is used for the treatment of type 2 diabetes in adults, when the disease cannot be adequately controlled by diet, exercise, or other antidiabetic drugs such as metformin or sulfonylureas alone.
Form: tablets, film-coated
Active substance Dosage linagliptin - ATC: A10BH05
Manufacturer: KRKA D.D. NOVO MESTO
-
It is used for the treatment of type 2 diabetes in adults, when the disease cannot be adequately controlled by diet, exercise, or other antidiabetic drugs (such as metformin or sulfonylureas) alone.
Form: tablets, film-coated
Active substance Dosage linagliptin - ATC: A10BH05
Manufacturer: MACLEODS PHARMA ESPANA, S.L.U.
-
It is used in adults for the treatment of type 2 diabetes, when the disease cannot be controlled by diet, exercise, or other antidiabetic drugs such as metformin or sulfonylureas alone.
Form: tablets, film-coated
Active substance Dosage linagliptin - ATC: A10BH05
Manufacturer: MYLAN S.P.A.
-
It is used for the treatment of type 2 diabetes in adults, when the disease cannot be adequately controlled by diet, exercise, or other antidiabetic drugs (such as metformin or sulfonylureas) alone.
Form: tablets, film-coated
Active substance Dosage linagliptin - ATC: A10BH05
Manufacturer: TOWA PHARMACEUTICAL S.P.A.
-
It is used for the treatment of type 2 diabetes in adults, when the disease cannot be adequately controlled by diet, exercise, or other antidiabetic drugs (such as metformin or sulfonylureas) alone.
Form: tablets, film-coated
Active substance Dosage linagliptin - ATC: A10BH05
Manufacturer: SANDOZ S.P.A.
-
It is used for the treatment of type 2 diabetes in adults, when the disease cannot be adequately controlled by diet, exercise, or other antidiabetic drugs (such as metformin or sulfonylureas) alone.
Form: tablets, film-coated
Active substance Dosage linagliptin - ATC: A10BH05
Manufacturer: ZENTIVA ITALIA S.R.L.
-
It is used for the treatment of type 2 diabetes in adults, when the disease cannot be adequately controlled by diet, exercise, or other antidiabetic drugs (such as metformin or sulfonylureas) alone. It helps to reduce blood sugar levels.
Form: tablets, film-coated
Active substance Dosage linagliptin - ATC: A10BH05
Manufacturer: BOEHRINGER INGELHEIM INTERNATIONAL GMBH